Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 17
Original Research
Reexamining Ophthalmic Drugs, Safety and Tolerability in Phase 1 Clinical Trials
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,893 | Dovepress* | 4,290+ | 124 | 4,414 | |
| PubMed Central* | 603 | 167 | 770 | ||
| Totals | 4,893 | 291 | 5,184 | ||
| *Since 21 October 2021 | |||||
View citations on PubMed and Google Scholar